rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

William Chou

President and CEO

Company insider

Files Form 4 as: President and CEO, Passage Bio.

In numbers

Trades disclosed
13
Buys
0
Sells
1
Bought
$0
Sold
$150K
Companies
1
Companies where not an officer
0
First trade
10 Oct 2022
Last trade
16 Mar 2026
Last filed
18 Mar 2026

Companies traded

Where they are an officer
PASG Passage BioDirector, Officer · Biotechnology · last 16 Mar 20260 buys · 1 sell

Activity over time

1 Jan – 1 Oct
10Jan 26Mar 26Jun 26Aug 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
16 Mar 2026filed 18 Mar 2026PASG Passage Biooption or derivative · BiotechnologySEC FORM 4 Code A—58,000 at $0.00filing
16 Mar 2026filed 18 Mar 2026PASG Passage Biooption or derivative · BiotechnologySEC FORM 4 Code A—58,000 at $0.00filing
8 Jan 2026filed 12 Jan 2026PASG Passage BioBiotechnologySEC FORM 4 Code M—10,000filing
8 Jan 2026filed 12 Jan 2026PASG Passage BioBiotechnologySEC FORM 4 Sold$75K4,076 at $18.44filing
8 Jan 2026filed 12 Jan 2026PASG Passage Biooption or derivative · BiotechnologySEC FORM 4 Code M—10,000 at $0.00filing
8 Jan 2026filed 12 Jan 2026PASG Passage Biooption or derivative · BiotechnologySEC FORM 4 Code M—10,000 at $0.00filing
8 Jan 2026filed 12 Jan 2026PASG Passage BioBiotechnologySEC FORM 4 Code M—10,000filing
8 Jan 2026filed 12 Jan 2026PASG Passage BioBiotechnologySEC FORM 4 Sold$75K4,076 at $18.44filing
15 Mar 2025filed 18 Mar 2025PASG Passage Biooption or derivative · BiotechnologySEC FORM 4 Code A—779,533 at $0.00filing
15 Jan 2025filed 29 Dec 2025PASG Passage Biooption or derivative · BiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
15 Mar 2024filed 19 Mar 2024PASG Passage Biooption or derivative · BiotechnologySEC FORM 4 Code A—575,000 at $0.00filing
15 Mar 2023filed 5 Apr 2023PASG Passage Biooption or derivative · BiotechnologySEC FORM 4 Code A—608,615 at $0.00filing
10 Oct 2022filed 12 Oct 2022PASG Passage Biooption or derivative · BiotechnologySEC FORM 4 Code A—885,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care1

Buys in green, sells in red, by the company’s sector.

Related people

Lynx1 Capital Management LP10% owner · 10% owner at Passage BIO, filing Form 4 there in the last year
Weston NicholsDirector · 10% owner at Passage BIO, filing Form 4 there in the last year
Athena CountouriotisDirector · Director at Passage BIO, filing Form 4 there in the last year
Sandip KapadiaDirector · Director at Passage BIO, filing Form 4 there in the last year
Derrell PorterDirector · Director at Passage BIO, filing Form 4 there in the last year